Kato Yojiro, Griesemer Adam D, Wu Anette, Sondermeijer Hugo P, Weiner Joshua I, Duran-Struuck Raimon, Martinez Mercedes, Slate Andrea R, Romanov Alexander, Lefkowitch Jay H, Sykes Megan, Kato Tomoaki
Departments of Surgery, Columbia Center for Translational Immunology, College of Physicians and Surgeons, Columbia University, New York, New York.
Columbia Center for Translational Immunology, College of Physicians and Surgeons, Columbia University, New York, New York.
Comp Med. 2017 Oct 1;67(5):436-441.
Cynomolgus monkeys are often used in preclinical transplantation research. Performing liver transplantation in cynomolgus monkeys is challenging because they poorly tolerate portal vein clamping during the anhepatic phase. Finding an alternative to portal vein clamping is necessary before preclinical liver transplant models can be performed with reliable outcomes. We used 3 different techniques to perform 5 liver transplants in male cynomolgus macaques (weight, 7.4-10.8 kg; mismatched for MHC I and II; matched for ABO). In procedure A, we clamped the portal vein briefly, as in human transplants, as well as the superior mesentery artery to minimize congestion at the expense of temporary ischemia (n = 2). In procedure B, we performed a temporary portocaval shunt with extracorporeal venovenous bypass (n = 1). For procedure C, we developed an H-shunt system (modified portocaval shunt) with extracorporeal bypass (n = 2). Postoperative immunosuppression comprised cyclosporine A, mycophenolate mofetil, and steroids. Recipients in procedure A developed hemodynamic instability and were euthanized within 2 d. The recipient that underwent procedure B was euthanized within 11 d due to inferior vena caval thrombosis. The H-shunt in procedure C led to minimal PV congestion during the anhepatic phase, and both recipients reached the 21-d survival endpoint with good graft function. Our novel H-shunt bypass system resulted in successful liver transplantation in cynomolgus macaques, with long-term posttransplant survival possible. This technical innovation makes possible the use of cynomolgus monkeys for preclinical liver transplant tolerance models.
食蟹猴常用于临床前移植研究。在食蟹猴身上进行肝移植具有挑战性,因为它们在无肝期对门静脉阻断的耐受性较差。在能够获得可靠结果的临床前肝移植模型得以开展之前,找到一种替代门静脉阻断的方法很有必要。我们采用3种不同技术,对5只雄性食蟹猴(体重7.4 - 10.8 kg;MHC I和II不匹配;ABO匹配)进行了肝移植。在手术A中,我们像在人类移植手术中那样短暂阻断门静脉以及肠系膜上动脉,以尽量减少充血,但代价是造成短暂缺血(n = 2)。在手术B中,我们通过体外静脉 - 静脉旁路进行了临时门腔分流术(n = 1)。对于手术C,我们开发了一种带有体外旁路的H形分流系统(改良门腔分流术)(n = 2)。术后免疫抑制包括环孢素A、霉酚酸酯和类固醇。手术A组的受体出现血流动力学不稳定,并在2天内实施安乐死。接受手术B的受体因下腔静脉血栓形成在11天内被安乐死。手术C中的H形分流术在无肝期导致门静脉充血最少,两名受体均达到21天生存终点,移植肝功能良好。我们新颖的H形分流旁路系统在食蟹猴中实现了成功的肝移植,移植后有可能长期存活。这项技术创新使得利用食蟹猴建立临床前肝移植耐受模型成为可能。